Furthermore, our study demonstrates the prominent prognostic effect of TIPRL on the HCC incidence and the patients’ survivability among other variables, including LC3, CD133, even CD46, and sex, which have reported their contributions in the HCCs incidence. The gene discussed is MAP1LC3A; the disease is hepatocellular carcinoma.